MedTrace Logo

Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

NCT01005784 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2009-11-02

No results posted yet for this study

Summary

This is a comparison of pregnancy achievement between two GnRH antagonist protocols which differ in the timing of GnRH antagonist initiation.

Conditions

  • Subfertility

Interventions

DRUG

Cetrorelix (Cetrotide)

flexible antagonist administration according to specified criteria

DRUG

Cetrorelix (Cetrotide)

fixed antagonist administration on day 6 of ovarian stimulation

Sponsors & Collaborators

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Efstratios Kolibianakis · Unit for Human Reproduction

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2008-01-31
Completion
2008-03-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01005784 on ClinicalTrials.gov